Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18429757 | 2-(BENZO[D]OXAZOL-2-YL)-N'- (ISONICOTINOYLOXY)ACETIMIDAMIDE AS AN ANTIMICROBIAL COMPOUND | February 2024 | August 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18429752 | 2-(BENZO[D]OXAZOL-2-YL)-N'- (ISONICOTINOYLOXY)ACETIMIDAMIDE AS AN ANTIMICROBIAL COMPOUND | February 2024 | August 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18419071 | Termite Trailing and Recruitment Product and Process | January 2024 | September 2024 | Allow | 8 | 2 | 0 | Yes | No |
| 18382731 | 2-(BENZO[D]OXAZOL-2-YL)-N'- (ISONICOTINOYLOXY)ACETIMIDAMIDE AS AN ANTIMICROBIAL COMPOUND | October 2023 | October 2024 | Allow | 12 | 2 | 1 | Yes | No |
| 18367829 | Termite Trailing and Recruitment Product and Process | September 2023 | June 2024 | Abandon | 9 | 1 | 0 | No | No |
| 18089652 | STABLE READY-TO-USE CARMUSTINE PHARMACEUTICAL COMPOSITION | December 2022 | November 2023 | Allow | 10 | 1 | 1 | Yes | No |
| 17871189 | PROCESSES FOR IMMOBILISING BIOLOGICAL ENTITIES | July 2022 | February 2024 | Allow | 19 | 1 | 1 | Yes | No |
| 17869665 | TOPICAL COMPOSITIONS | July 2022 | March 2024 | Allow | 19 | 2 | 1 | No | No |
| 17725320 | COMPOSITIONS FOR THE TREATMENT OF HYPERKERATOSIS DISORDERS | April 2022 | September 2024 | Abandon | 29 | 1 | 1 | Yes | No |
| 17695166 | HETEROCYCLIC-DITHIOL CLICK CHEMISTRY | March 2022 | September 2024 | Allow | 30 | 2 | 1 | No | No |
| 17685038 | TREPROSTINIL DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | March 2022 | July 2024 | Allow | 29 | 2 | 1 | Yes | No |
| 17577564 | PYRROLIDINONES AS HERBICIDES | January 2022 | July 2022 | Allow | 6 | 1 | 0 | Yes | No |
| 17531731 | Plug Product and a Method of Using the Plug Product for Tooth-Associated Pain | November 2021 | October 2024 | Abandon | 35 | 0 | 1 | No | No |
| 17519377 | PLANT HEALTH EFFECT OF PURPUREOCILLIUM LILACINUM | November 2021 | October 2024 | Abandon | 35 | 2 | 1 | Yes | No |
| 17507413 | COMPOSITION FOR SKIN WHITENING COMPRISING CARVEDILOL | October 2021 | August 2024 | Abandon | 34 | 2 | 1 | Yes | No |
| 17490885 | MICRONUTRIENT COMPOSITIONS AND SYSTEMS AND METHODS OF USING SAME | September 2021 | April 2024 | Abandon | 31 | 1 | 1 | No | No |
| 17468717 | NATURAL LUBRICANT COMPOSITION AND A TABLET | September 2021 | September 2023 | Allow | 25 | 1 | 1 | Yes | No |
| 17468293 | METHOD FOR INHIBITING CORONAVIRUS AND METHOD FOR TREATING DISEASE ASSOCIATED WITH CORONAVIRUS INFECTION | September 2021 | October 2024 | Abandon | 37 | 2 | 1 | No | No |
| 17403679 | Lip Balm Containing Caffeine, Nicotine or Testosterone | August 2021 | April 2024 | Allow | 32 | 1 | 1 | Yes | No |
| 17378485 | MULTILAYER WATER DISPERSIBLE FILM HAVING IMPROVED GERMINATION OF SEEDS AND SOIL FERTILITY | July 2021 | December 2024 | Abandon | 41 | 2 | 1 | Yes | No |
| 17373714 | NOVEL GLUE FOR EMBOLIZATION OF LYMPHATIC LEAKAGE | July 2021 | February 2024 | Abandon | 31 | 1 | 1 | No | No |
| 17421710 | PHARMACEUTICAL COMPOSITION COMPRISING SPHERICAL AGGLOMERATES OF TIMAPIPRANT | July 2021 | June 2024 | Abandon | 36 | 2 | 0 | No | No |
| 17421701 | PROCESS FOR PREPARING SPHERICAL AGGLOMERATES OF TIMAPIPRANT | July 2021 | June 2024 | Abandon | 36 | 2 | 0 | Yes | No |
| 17297349 | COSMETIC COMPOSITIONS AND METHODS OF USE | May 2021 | November 2024 | Abandon | 42 | 2 | 1 | No | No |
| 17317829 | OXYGEN-GENERATING BIODEGRADABLE SURGICAL MESH | May 2021 | October 2024 | Abandon | 42 | 2 | 1 | No | No |
| 17315382 | Neutralizing Agent with Disinfectant and Deodorizing Effect | May 2021 | February 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17290234 | COMPOSITIONS COMPRISING HALAUXIFEN AND OTHER HERBICIDES AND METHODS THEREOF | April 2021 | August 2024 | Abandon | 39 | 1 | 0 | No | No |
| 17229265 | Method Of Treating Inflammation | April 2021 | May 2024 | Abandon | 37 | 1 | 1 | No | No |
| 17268022 | STABLE READY-TO-USE CARMUSTINE PHARMACEUTICAL COMPOSITION | February 2021 | May 2023 | Abandon | 27 | 2 | 1 | Yes | No |
| 17267656 | METHOD FOR TREATING PRIMARY SCLEROSING CHOLANGITIS | February 2021 | October 2024 | Abandon | 45 | 1 | 1 | No | No |
| 17157701 | COMPOSITIONS COMPRISING ORGANIC MINERAL CHELATES, NIACINAMIDE, AND HEMP OIL AND USES THEREOF FOR NEUROPROTECTION, CARDIOPROTECTION, DETOXIFICATION, IMMUNE SUPPORT, AND ANTI-AGING | January 2021 | January 2024 | Abandon | 36 | 1 | 1 | No | No |
| 17145716 | WAVELENGTH SPECTRUM ENHANCEMENT FOR PLANT PHOTOSYNTHESIS | January 2021 | October 2023 | Abandon | 33 | 1 | 1 | No | No |
| 17134800 | ENCAPSULATING AGENT WITH IMPROVED PROPERTIES ADAPTED FOR CELL ENCAPSULATION | December 2020 | March 2023 | Abandon | 27 | 0 | 1 | No | No |
| 17129697 | Methods for Producing Fullerene that is Bioavailable via Inhalation or Other Absorption Modality | December 2020 | May 2023 | Allow | 29 | 1 | 1 | Yes | No |
| 17126901 | MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION, IMMEDIATE RELEASE PELLETS, SUSTAINED RELEASE PELLETS, ENTERIC RELEASE PELLETS AND USE THEREOF | December 2020 | April 2023 | Abandon | 28 | 2 | 0 | No | No |
| 17253206 | PESTICIDALLY ACTIVE AZETIDINE SULFONES AMIDE ISOXAZOLINE DERIVATIVES | December 2020 | May 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17252349 | COMPOUNDS HAVING A NITROGEN-CONTAINING UNSATURATED SIX-MEMBERED RING AND AGRICULTURAL AND HORTICULTURAL FUNGICIDES CONTAINING THE SAME AS ACTIVE INGREDIENTS | December 2020 | June 2024 | Allow | 42 | 2 | 1 | Yes | No |
| 17118312 | SURFACTANTS FOR AGRICULTURAL PRODUCTS | December 2020 | September 2023 | Allow | 33 | 2 | 1 | Yes | No |
| 17056151 | THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS | November 2020 | November 2024 | Abandon | 48 | 2 | 1 | Yes | No |
| 17095997 | READY TO USE BIODEGRADABLE AND BIOCOMPATIBLE CELL-BASED NERVE CONDUIT FOR NERVE INJURY AND A METHOD OF PREPARATION THEREOF | November 2020 | December 2023 | Allow | 37 | 1 | 1 | Yes | No |
| 17053837 | NEAR-IR ACTIVATABLE FLUORESCENT SMALL MOLECULES WITH DUAL MODES OF CYTOTOXICITY | November 2020 | January 2023 | Allow | 26 | 2 | 0 | Yes | No |
| 17092257 | COMBINATION THERAPEUTICS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE AND OTHER DISEASES | November 2020 | January 2023 | Abandon | 26 | 1 | 1 | No | No |
| 17089497 | ELECTROSPRAYED AND ELECTROSPUN CANNABINOID COMPOSITIONS AND PROCESS TO PRODUCE | November 2020 | July 2023 | Abandon | 32 | 1 | 1 | Yes | No |
| 17047027 | HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES | October 2020 | June 2024 | Allow | 44 | 1 | 1 | Yes | No |
| 17039859 | PROBIOTIC MICROCAPSULE | September 2020 | November 2023 | Allow | 38 | 2 | 1 | Yes | No |
| 17041919 | ESTERS OF HETEROCYCLIC COMPOUNDS HAVING A NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND THEIR USE | September 2020 | February 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17029580 | HIP LABRUM SCAFFOLDS | September 2020 | November 2024 | Abandon | 50 | 4 | 1 | Yes | No |
| 16981643 | BONEGRAFT SUBSTITUTE AND METHOD OF MANUFACTURE | September 2020 | March 2024 | Allow | 42 | 3 | 1 | Yes | No |
| 16999871 | REACTIVE MULTI-ARM POLYMERS HAVING BRANCHED END GROUPS | August 2020 | August 2024 | Allow | 48 | 3 | 1 | Yes | Yes |
| 16961147 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LUNG EMPHYSEMA AND OTHER FORMS OF COPD | July 2020 | January 2024 | Abandon | 42 | 4 | 0 | Yes | No |
| 16920460 | TOPICAL COMPOSITIONS | July 2020 | October 2022 | Abandon | 27 | 1 | 0 | No | No |
| 16901602 | ANTIBACTERIAL PHOTODYNAMIC THERAPY USING COPPER-CYSTEAMINE NANOPARTICLES | June 2020 | August 2024 | Allow | 50 | 2 | 1 | Yes | Yes |
| 16767611 | PESTICIDAL COMPOSITIONS AND METHODS | May 2020 | July 2023 | Abandon | 38 | 2 | 1 | No | No |
| 16767726 | MICROBIOCIDAL THIAZOLE DERIVATIVES | May 2020 | September 2023 | Allow | 39 | 3 | 1 | Yes | No |
| 16767048 | HETEROCYCLIC COMPOUNDS AS PESTICIDES | May 2020 | November 2022 | Abandon | 29 | 0 | 1 | No | No |
| 16877980 | SUPRAMOLECULAR BIOMEDICAL POLYMERS | May 2020 | September 2023 | Allow | 40 | 3 | 1 | Yes | No |
| 16763939 | METHOD FOR MANUFACTURING A HYPERBRANCHED POLYESTER POLYOL DERIVATIVE | May 2020 | December 2024 | Abandon | 55 | 4 | 0 | No | Yes |
| 16763737 | METHOD FOR INDUCING ACQUIRED RESISTANCE IN A PLANT | May 2020 | July 2024 | Allow | 50 | 4 | 0 | Yes | No |
| 15930799 | USE OF HIF-2alpha INHIBITORS FOR TREATING CHONDROSARCOMA, OR PREVENTING RECURRENCE AND METASTASIS THEREOF | May 2020 | February 2023 | Allow | 33 | 2 | 1 | Yes | No |
| 16762345 | S1PR2 ANTAGONISTS FOR TREATING DISEASES INVOLVING ABNORMAL IMMUNE RESPONSES | May 2020 | June 2022 | Abandon | 25 | 0 | 1 | No | No |
| 16760784 | ANTIMICROBIAL FLOOR COATINGS AND FORMULATIONS | April 2020 | March 2024 | Abandon | 46 | 4 | 0 | Yes | No |
| 16757119 | Macrophage Targeted Immunotherapeutics | April 2020 | November 2023 | Abandon | 43 | 3 | 1 | Yes | No |
| 16756045 | HERBICIDAL FORMULATION IN THE FORM OF MICROEMULSION | April 2020 | February 2024 | Abandon | 46 | 4 | 1 | No | No |
| 16844151 | BIOLOGICAL FUNGICIDE COMPOSED BY PLANT EXTRACTS | April 2020 | September 2021 | Allow | 18 | 2 | 0 | Yes | No |
| 16832264 | COATING FOR JOINT IMPLANTS | March 2020 | March 2024 | Abandon | 47 | 2 | 1 | No | No |
| 16650623 | COMPOSITIONS FOR WOUND TREATMENT | March 2020 | May 2023 | Abandon | 38 | 1 | 1 | No | No |
| 16649621 | Pyrazine-4-Carbamate or -Urea Derivatives As Herbicides | March 2020 | February 2023 | Allow | 34 | 2 | 1 | No | No |
| 16820232 | FLEXIBLE HOLLOW STRUCTURE, ADHESIVE TAPE, AND FUNCTIONAL ADHESIVE SHEET | March 2020 | January 2023 | Abandon | 34 | 0 | 1 | No | No |
| 16815756 | MACRONUTRIENT COMPOUNDS | March 2020 | October 2023 | Abandon | 43 | 2 | 1 | No | No |
| 16644707 | ACETIC ACID-BASED HERBICIDE COMPOSITION | March 2020 | January 2024 | Abandon | 46 | 3 | 2 | Yes | No |
| 16643345 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE | February 2020 | September 2023 | Abandon | 42 | 2 | 1 | Yes | No |
| 16792400 | METHOD AND COMPOSITION FOR INHIBITING THE GROWTH OF PSEUDOMONAS SYRINGAE ON A PLANT MATERIAL, AND KIT FOR TREATING THE SAME | February 2020 | October 2023 | Abandon | 44 | 3 | 1 | No | No |
| 16639322 | HERBICIDAL COMPOSITION | February 2020 | May 2023 | Abandon | 39 | 2 | 1 | No | No |
| 16635039 | SYSTEMS AND METHODS FOR WOUND DEBRIDEMENT | January 2020 | May 2023 | Abandon | 39 | 0 | 1 | No | No |
| 16751441 | AGRICULTURAL ADJUVANT COMPRISING MICROFIBRILLATED CELLULOSE | January 2020 | April 2024 | Allow | 51 | 3 | 1 | Yes | No |
| 16750735 | MULTIFUNCTIONAL AGRICULTURAL ADJUVANT COMPOSITIONS | January 2020 | September 2023 | Allow | 44 | 7 | 1 | Yes | No |
| 16631624 | SUBSTITUTED 3-HETEROARYLOXY-1H-PYRAZOLES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCES | January 2020 | August 2022 | Abandon | 31 | 0 | 1 | No | No |
| 16631393 | COATED IMPLANTABLE DEVICE | January 2020 | April 2024 | Allow | 51 | 4 | 1 | Yes | No |
| 16630330 | HETEROCYCLIC-DITHIOL CLICK CHEMISTRY | January 2020 | August 2022 | Abandon | 31 | 1 | 1 | No | No |
| 16618121 | SPRAY COMPOSITIONS OF CHITOSAN FOR WOUND HEALING | November 2019 | August 2023 | Abandon | 45 | 4 | 0 | No | No |
| 16617238 | COSMETIC | November 2019 | April 2023 | Allow | 41 | 4 | 0 | No | No |
| 16695888 | DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF | November 2019 | February 2023 | Abandon | 39 | 2 | 1 | No | No |
| 16484536 | PURIFIED POLLEN PARTICLES AND USE THEREOF FOR ADMINISTERING NANOSYSTEMS | November 2019 | July 2024 | Abandon | 59 | 3 | 1 | No | No |
| 16684157 | METHOD OF MAKING A FLAVONOID SOLUTION AND APPLICATIONS THEREOF FOR PLANT GROWTH PROMOTION, SEED COATING, PATHOGEN ELIMINATION, AND HERBICIDE STUNTING EFFECT REMOVAL | November 2019 | February 2024 | Allow | 51 | 6 | 1 | Yes | No |
| 16613078 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | November 2019 | March 2024 | Allow | 52 | 4 | 1 | Yes | No |
| 16676077 | METHODS AND MATERIALS FOR IMMUNOMODULATION OF TISSUE GRAFTS | November 2019 | January 2023 | Abandon | 38 | 0 | 1 | No | No |
| 16665217 | HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF | October 2019 | September 2021 | Abandon | 23 | 1 | 1 | No | No |
| 16600489 | AGRICULTURAL MICROBIAL COATING | October 2019 | October 2022 | Abandon | 36 | 3 | 1 | Yes | No |
| 16604354 | AGED ROSE EXTRACT AND PREPARATION METHOD THEREOF | October 2019 | May 2023 | Abandon | 43 | 3 | 0 | No | No |
| 16499333 | EX-VIVO CULTURE SYSTEM AND METHODS OF USING SAME | September 2019 | January 2024 | Allow | 51 | 4 | 1 | Yes | No |
| 16498897 | COMPOUNDS AND METHODS USEFUL FOR TREATING OR PREVENTING CANCERS | September 2019 | November 2022 | Allow | 38 | 2 | 1 | Yes | No |
| 16498006 | ALLEVIATION OF CORN ROOTWORM DAMAGE WITH MICROBIAL SEED TREATMENTS | September 2019 | February 2022 | Abandon | 28 | 2 | 0 | Yes | No |
| 16546400 | ANTIBACTERIAL COLLOID AND METHOD FOR MANUFACTURING THE SAME | August 2019 | November 2023 | Abandon | 51 | 4 | 1 | No | No |
| 16485834 | HERBICIDAL MIXTURE FOR USE ON WEEDS | August 2019 | September 2021 | Abandon | 25 | 0 | 1 | No | No |
| 16538866 | Lip Balm Containing Caffeine, Nicotine or Testosterone | August 2019 | October 2021 | Abandon | 27 | 3 | 0 | Yes | No |
| 16479586 | LYOPHILIZED PLACENTAL COMPOSITE SHEET AND USES THEREOF | July 2019 | November 2020 | Abandon | 16 | 1 | 1 | No | No |
| 16510466 | NANOFORMULATIONS OF NEUROPEPTIDES AND METHOD OF MAKING SAME | July 2019 | September 2021 | Abandon | 26 | 3 | 0 | Yes | No |
| 16508406 | ENCAPSULATED SEED | July 2019 | August 2024 | Abandon | 60 | 8 | 0 | Yes | No |
| 16455966 | Skin Care Composition | June 2019 | April 2024 | Abandon | 57 | 6 | 1 | Yes | No |
| 16457173 | ION INCORPORATED PLASMA SPRAYED HYDROXYAPATITE COATINGS AND METHOD OF MAKING THE SAME | June 2019 | August 2024 | Abandon | 60 | 6 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SILVERMAN, JANICE Y.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 42.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner SILVERMAN, JANICE Y works in Art Unit 1616 and has examined 139 patent applications in our dataset. With an allowance rate of 26.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.
Examiner SILVERMAN, JANICE Y's allowance rate of 26.6% places them in the 3% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SILVERMAN, JANICE Y receive 2.64 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by SILVERMAN, JANICE Y is 41 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +48.0% benefit to allowance rate for applications examined by SILVERMAN, JANICE Y. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 13.1% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 12.5% of cases where such amendments are filed. This entry rate is in the 12% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 0% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 57.1% of appeals filed. This is in the 29% percentile among all examiners. Of these withdrawals, 25.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 105.3% are granted (fully or in part). This grant rate is in the 94% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.